β¨ Medicines Distribution Consents
2784
NEW ZEALAND GAZETTE
No. 91
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Spirapril 6 mg | Tablet | Sandoz Pharma Limited, Basle, Switzerland | Sandopril |
| Diclofenac sodium 100 mg | Tablet (sustained release) | Laboratoria Wolfs B V B A, Antwerp, Belgium | Difen SR |
| Selegiline hydrochloride 5 mg | Tablet | Apotex Inc., Weston, Ontario, Canada | Apo-Selegiline |
| Nifedipine 10 mg | Tablet | Hexal-Pharma GmbH, Holzkirchen, Germany | Fedrem |
| Flecainide acetate 50 mg | Capsule | Pacific Pharmaceuticals Limited, Mt Wellington, Auckland | Tabco 50 |
| Note: Not to be marketed as substitutable for any other flecainide acetate product as if the two (2) products were bioequivalent. | |||
| Flecainide acetate 100 mg | Tablet | Pacific Pharmaceuticals Limited, Mt Wellington, Auckland | Tabco 100 |
| Note: Not to be marketed as substitutable for any other flecainide acetate product as if the two (2) products were bioequivalent. | |||
| Rocuronium bromide 50 mg in 5 ml, 100 mg in 10 ml | Injection | N V Organon, Oss, The Netherlands and Organon Laboratories Limited, Newhouse, Motherwell, Lanarkshire, Scotland | Esmeron |
Dated this 2nd day of September 1994.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
g06649
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Pentastarch 10% | Solution for infusion | Nederlands Productielaboratorium Voor Bloedtransfusieapparatuur en Infusieevloeistoffen BV (NPBI BV), Emmer-Compascuum, The Netherlands | Pentaspan |
Dated this 31st day of August 1994.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
g06651
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| 300 mcg Anti D (Rhβ) Immunoglobulin (>820IU) | Solution for IM injection | Ortho Diagnostics Inc., Raritan, New Jersey, United States of America | RhoGAM |
Conditions:
-
The above provisional consent is valid for six (6) months from the date of publication of this notice.
-
The health care professional who prescribes or administers RhoGAM must report its use to Auckland Healthcare Limited on a standardised form. The standardised form must contain the name and address of the health care professional and patient, and the reason, place and date of administration.
-
On a monthly basis, Auckland Healthcare Limited are required to forward the user information forms to the Ministry of Health along with information detailing the amounts of RhoGAM distributed and the sites to which it was distributed.
Dated this 1st day of September 1994.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
g06652
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1994, No 91
NZLII —
NZ Gazette 1994, No 91
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare2 September 1994
Medicines, Distribution, Consent, Medicines Act 1981
- C. Lovelace, Director-General of Health
π₯ Provisional Consent to the Distribution of Pentastarch 10%
π₯ Health & Social Welfare31 August 1994
Medicines, Distribution, Consent, Pentastarch, Medicines Act 1981
- C. Lovelace, Director-General of Health
π₯ Provisional Consent to the Distribution of RhoGAM
π₯ Health & Social Welfare1 September 1994
Medicines, Distribution, Consent, RhoGAM, Medicines Act 1981
- C. Lovelace, Director-General of Health